Targeting Mitochondrial Quality Control: New Therapeutic Strategies for Major Diseases

Overview

Journal Mil Med Res

Publisher Biomed Central

Specialty Emergency Medicine

Date 2024 Aug 20

PMID 39164792

Authors

Wei-Long Hong

He Huang

Xue Zeng

Chen-Yang Duan

Affiliations

Soon will be listed here.

Abstract

Mitochondria play a crucial role in maintaining the normal physiological state of cells. Hence, ensuring mitochondrial quality control is imperative for the prevention and treatment of numerous diseases. Previous reviews on this topic have however been inconsistencies and lack of systematic organization. Therefore, this review aims to provide a comprehensive and systematic overview of mitochondrial quality control and explore the possibility of targeting the same for the treatment of major diseases. This review systematically summarizes three fundamental characteristics of mitochondrial quality control, including mitochondrial morphology and dynamics, function and metabolism, and protein expression and regulation. It also extensively examines how imbalances in mitochondrial quality are linked to major diseases, such as ischemia-hypoxia, inflammatory disorders, viral infections, metabolic dysregulations, degenerative conditions, and tumors. Additionally, the review explores innovative approaches to target mitochondrial quality control, including using small molecule drugs that regulate critical steps in maintaining mitochondrial quality, nanomolecular materials designed for precise targeting of mitochondria, and novel cellular therapies, such as vesicle therapy and mitochondrial transplantation. This review offers a novel perspective on comprehending the shared mechanisms underlying the occurrence and progression of major diseases and provides theoretical support and practical guidance for the clinical implementation of innovative therapeutic strategies that target mitochondrial quality control for treating major diseases.

Citing Articles

Lysosome-Mitochondrial Crosstalk in Cellular Stress and Disease.

Kiraly S, Stanley J, Eden E Antioxidants (Basel). 2025; 14(2).

PMID: 40002312 PMC: 11852311. DOI: 10.3390/antiox14020125.

A rhodamine-coordinated iridium complex to overcome cisplatin-resistant cancer via regulating mitochondrial function triggered apoptosis and ferroptosis.

Li J, Gao G, Ouyang W, Huang J, Liu H, Li J Redox Biol. 2025; 81:103536.

PMID: 39956024 PMC: 11872635. DOI: 10.1016/j.redox.2025.103536.

Plant Secondary Metabolites as Modulators of Mitochondrial Health: An Overview of Their Anti-Oxidant, Anti-Apoptotic, and Mitophagic Mechanisms.

Anchimowicz J, Zielonka P, Jakiela S Int J Mol Sci. 2025; 26(1.

PMID: 39796234 PMC: 11720160. DOI: 10.3390/ijms26010380.

The multifaceted role of mitochondria in cardiac function: insights and approaches.

Ravindran S, Rau C Cell Commun Signal. 2024; 22(1):525.

PMID: 39472951 PMC: 11523909. DOI: 10.1186/s12964-024-01899-x.

Exploring the Mechanism of Ferroptosis Induction by Sappanone A in Cancer: Insights into the Mitochondrial Dysfunction Mediated by NRF2/xCT/GPX4 Axis.

Wang J, Zhuang H, Yang X, Guo Z, Zhou K, Liu N Int J Biol Sci. 2024; 20(13):5145-5161.

PMID: 39430236 PMC: 11488586. DOI: 10.7150/ijbs.96748.

References

Mehrzadi S, Karimi M, Fatemi A, Reiter R, Hosseinzadeh A . SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin. Pharmacol Ther. 2021; 224:107825. PMC: 7919585. DOI: 10.1016/j.pharmthera.2021.107825. View

Fields M, Marcuzzi A, Gonelli A, Celeghini C, Maximova N, Rimondi E . Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations. Int J Mol Sci. 2023; 24(4). PMC: 9960436. DOI: 10.3390/ijms24043739. View

Ong S, Subrayan S, Lim S, Yellon D, Davidson S, Hausenloy D . Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation. 2010; 121(18):2012-22. DOI: 10.1161/CIRCULATIONAHA.109.906610. View

Li P, Chen T, Kuang P, Liu F, Li Z, Liu F . Aurora-A/FOXO3A/SKP2 axis promotes tumor progression in clear cell renal cell carcinoma and dual-targeting Aurora-A/SKP2 shows synthetic lethality. Cell Death Dis. 2022; 13(7):606. PMC: 9279325. DOI: 10.1038/s41419-022-04973-9. View

Alberici L, Oliveira H . Mitochondrial Adaptive Responses to Hypertriglyceridemia and Bioactive Lipids. Antioxid Redox Signal. 2021; 36(13-15):953-968. DOI: 10.1089/ars.2021.0180. View

Hamed M, Logan A, Gruszczyk A, Beach T, James A, Dare A . Mitochondria-targeted antioxidant MitoQ ameliorates ischaemia-reperfusion injury in kidney transplantation models. Br J Surg. 2021; 108(9):1072-1081. DOI: 10.1093/bjs/znab108. View

Lohr K, Frost B, Scherzer C, Feany M . Biotin rescues mitochondrial dysfunction and neurotoxicity in a tauopathy model. Proc Natl Acad Sci U S A. 2020; 117(52):33608-33618. PMC: 7777082. DOI: 10.1073/pnas.1922392117. View

Hao S, Huang H, Ma R, Zeng X, Duan C . Multifaceted functions of Drp1 in hypoxia/ischemia-induced mitochondrial quality imbalance: from regulatory mechanism to targeted therapeutic strategy. Mil Med Res. 2023; 10(1):46. PMC: 10571487. DOI: 10.1186/s40779-023-00482-8. View

Li X, Pu W, Zheng Q, Ai M, Chen S, Peng Y . Proteolysis-targeting chimeras (PROTACs) in cancer therapy. Mol Cancer. 2022; 21(1):99. PMC: 8996410. DOI: 10.1186/s12943-021-01434-3. View

10.

DAcunzo P, Perez-Gonzalez R, Kim Y, Hargash T, Miller C, Alldred M . Mitovesicles are a novel population of extracellular vesicles of mitochondrial origin altered in Down syndrome. Sci Adv. 2021; 7(7). PMC: 7880603. DOI: 10.1126/sciadv.abe5085. View

11.

Crewe C, Funcke J, Li S, Joffin N, Gliniak C, Ghaben A . Extracellular vesicle-based interorgan transport of mitochondria from energetically stressed adipocytes. Cell Metab. 2021; 33(9):1853-1868.e11. PMC: 8429176. DOI: 10.1016/j.cmet.2021.08.002. View

12.

Todkar K, Chikhi L, Desjardins V, El-Mortada F, Pepin G, Germain M . Selective packaging of mitochondrial proteins into extracellular vesicles prevents the release of mitochondrial DAMPs. Nat Commun. 2021; 12(1):1971. PMC: 8009912. DOI: 10.1038/s41467-021-21984-w. View

13.

Manczak M, Kandimalla R, Fry D, Sesaki H, Reddy P . Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease. Hum Mol Genet. 2016; 25(23):5148-5166. PMC: 6078633. DOI: 10.1093/hmg/ddw330. View

14.

Borsche M, Pereira S, Klein C, Grunewald A . Mitochondria and Parkinson's Disease: Clinical, Molecular, and Translational Aspects. J Parkinsons Dis. 2020; 11(1):45-60. PMC: 7990451. DOI: 10.3233/JPD-201981. View

15.

Wang Y, Jasper H, Toan S, Muid D, Chang X, Zhou H . Mitophagy coordinates the mitochondrial unfolded protein response to attenuate inflammation-mediated myocardial injury. Redox Biol. 2021; 45:102049. PMC: 8246635. DOI: 10.1016/j.redox.2021.102049. View

16.

Thompson W, Hornby B, Manuel R, Bradley E, Laux J, Carr J . A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism. Genet Med. 2020; 23(3):471-478. PMC: 7935714. DOI: 10.1038/s41436-020-01006-8. View

17.

Li Y, Huang D, Jia L, Shangguan F, Gong S, Lan L . LonP1 Links Mitochondria-ER Interaction to Regulate Heart Function. Research (Wash D C). 2023; 6:0175. PMC: 10275618. DOI: 10.34133/research.0175. View

18.

Tian L, Neuber-Hess M, Mewburn J, Dasgupta A, Dunham-Snary K, Wu D . Ischemia-induced Drp1 and Fis1-mediated mitochondrial fission and right ventricular dysfunction in pulmonary hypertension. J Mol Med (Berl). 2017; 95(4):381-393. PMC: 5390778. DOI: 10.1007/s00109-017-1522-8. View

19.

Eldeeb M, Thomas R, Ragheb M, Fallahi A, Fon E . Mitochondrial quality control in health and in Parkinson's disease. Physiol Rev. 2022; 102(4):1721-1755. DOI: 10.1152/physrev.00041.2021. View

20.

Satish S, Philipose H, Rosales M, Saint-Geniez M . Pharmaceutical Induction of PGC-1 Promotes Retinal Pigment Epithelial Cell Metabolism and Protects against Oxidative Damage. Oxid Med Cell Longev. 2018; 2018:9248640. PMC: 6247391. DOI: 10.1155/2018/9248640. View